Why Are Veterinarians Prescribing Organic Trace Mineral Products?

Trace minerals play a vital role in several metabolic functions in the animal body. These minerals can be derived from organic as well as inorganic sources. Inorganic trace minerals, such as sulphates, carbonates, chlorides, and oxides of elements, interact with tannin, fiber, silicates, oxalate, phytate, and other minerals in the gastrointestinal tract of animals, thereby affecting the feed absorption process. As organic trace minerals such as selenium, zinc, copper, and manganese improve gut absorption in animals, they are being increasingly used in animal feed. 

Organic Trace Minerals Market Outlook

As organic trace minerals also include iron, the surging iron deficiency among poultry and ruminants will help the organic trace minerals market register significant growth in the coming years. Additionally, the mounting focus of animal farm owners on strengthening animal immunity will create a huge requirement for minerals such as copper and manganese in the foreseeable future. Furthermore, the surge in the number of animal farms is propelling the demand for organic trace minerals, as veterinarians are increasingly recommending using these products in animal feed. 

According to P&S Intelligence, North America dominates the organic trace minerals market, due to the surging customer awareness about the advantages of organic products in the region. Additionally, the implementation of stringent environmental regulations is limiting the use of inorganic minerals, which is, in turn, fueling the adoption of organic trace minerals in the region. Furthermore, the Asia-Pacific (APAC) region is also adopting a considerable volume of organic trace minerals, due to the soaring consumption and export of milk products and meat in the region. 

Thus, the rising emphasis on animal health and enhanced productivity, escalating demand for milk products and milk, and growing prevalence of iron deficiency among animals will encourage the use of organic trace mineral products in the coming years.  

Explore Full Report Description At: https://www.psmarketresearch.com/market-analysis/organic-trace-minerals-market

Read More

What is the Present and Future Outlook of the Interventional Radiology Market on the Basis of Region?

There are different types of products available in the interventional radiology market, including magnetic resonance imaging (MRI), ultrasound, computed tomography (CT), angiography systems, and others. The market for ultrasound systems is estimated to progress substantially during the forecast period, registering a CAGR of 6.2%. The reason for such growth would be the increasing prevalence of birth disorders and chronic diseases that are boosting the demand for ultrasound systems globally.

Furthermore, the domain, on the basis of application, is categorized into cardiology, oncology, gastroenterology, urology and nephrology, obstetrics and gynecology, and others. Out of these, oncology is estimated to contribute the most significant share to the interventional radiology market in the forecast period. The oncology segment is expected to generate $5.1 billion revenue for the market in 2018 and $7.3 billion by 2024. Across the globe, the increasing prevalence of cancer has boosted this segment. Furthermore, the market for gastroenterology is also expected to experience significant growth, progressing at a CAGR of5.9% during the analysis period.

Across the globe, the interventional radiology market is registering growth owing to a substantial number of new equipment being introduced by prominent players. For instance, Canon Medical Systems Corporation, within its Vitrea platform, launched the illumination rendering technology in January 2019. This will enable real-time interaction with photorealistic images, allowing physicians to visualize patient’s anatomy in all dimensions. That same year, Canon also launched the Aquilian Start CT system in Dubai.

Read More.

Read More

Europe Cleanroom Technology Market Set for Prosperity in Future

The prevalence of infectious diseases is growing rapidly all across the globe, including Europe. A very recent example is that of the COVID-19, which is spreading at a very quick pace around the world. The fact that there’s no vaccine yet for curing the diseases is a major cause of concern. European countries, including Italy and the U.K. have been hot hardly by this deadly virus, owing to which the demand for the cleanroom technology in the region is rising, as they are vital for the drug development process. 

This is due to the fact that these products are used widely for maintaining the aseptic environment in a number of industries. Safety, including apparel and gloves, and cleaning, vacuum systems, wipes, and disinfectants, are the two types of consumable that are used in cleanrooms. Different types of cleanrooms are pass-through cleanrooms, standard cleanrooms, softwall cleanrooms, and hardwall cleanrooms. Out of these, the demand for standard cleanrooms was the highest in the past, which is due to the presence of large medical device and pharmaceutical companies that opt for standard cleanrooms to produce critical products. 

Other than this, the demand for hardwall cleanrooms is also predicted to increase in the years to come, which can be ascribed to the rising research and development activities in pharmaceuticals in the region. The process involves heavy usage of hardwall cleanrooms, which are designed specifically for research activities. Medical devices, pharmaceutical, and biotechnology industries are the major users of cleanrooms in the European region. The pharmaceutical industry made the most use of cleanrooms in the past, owing to the growing number of pharma companies and increasing investments in pharmaceutical research activities. 

Hence, the demand for cleanrooms in Europe is growing due to the surging prevalence of infectious diseases. 

Read More

Why Are Parents Opting for Baby Shampoos and Conditioners?

Sanitation and hygiene are the most vital aspects of baby care and shampoos and conditioners are inherent constituents of baby care. As babies are fragile and delicate, hygiene and sanitation products of adults are not recommended to be used on babies. Nowadays, parents have become very cautious about the brands of baby shampoos and conditioners, owing to the mounting awareness about the hygiene of babies. Owing to this reason, parents are now preferring to use toxin and paraben-free baby shampoo and conditioners.

Baby Shampoo and Conditioners Market Outlook

Moreover, the accelerating urbanization rate in populous countries, such as India and China, will steer the baby shampoo and conditioners market growth in the forthcoming years. Increasing urbanization rate in such countries has encouraged parents to amplify their focus on the nurture of their child, owing to which, they have surged their expenditure on baby care products. Additionally, the declining global infant mortality rate will also augment the use of baby shampoos and conditioners in the upcoming years. According to the World Bank, the global infant mortality rate has declined from 64.5 in 1960 to 28.2 in 2019. 

According to P&S Intelligence, Europe dominated the baby shampoo and conditioners market in the preceding years. Asia-Pacific (APAC) has also emerged as a major procurer of baby shampoos and conditioners in recent years. This can be primarily owed to the booming population and increasing fertility rate of women in China and India. For instance, the World Bank states that the fertility rate of China and India stood at 1.7 and 2.2, respectively, in 2019. Furthermore, the World Economic Forum (WEF) forecasts that the population of India will surpass 1.6 billion by 2060.  

Therefore, the surging awareness among parents about baby hygiene and sanitation and the booming population will amplify the use of baby shampoos and conditioners in the foreseeable future. Moreover, the declining infant mortality rate, owing to the improving healthcare infrastructure, will also propel the consumption of such baby care products in the forthcoming years.  

Explore Full Report Description At: https://www.psmarketresearch.com/market-analysis/baby-shampoo-and-conditioners-market

Read More

What are Major Factors Driving Growth of Digital Health Market?

 The geriatric population, specifically that of people in the age group of 65 and above, is about to reach 1.5 billion in 2050 from 703 million in 2019, as per the World Population Ageing 2019 report of the United Nations (UN). It is a well-known fact that the elderly fall sick often, for long periods, as they have compromised immune systems and low physical strength. On account of the latter factor, many of them also find it extremely difficult to go to a doctor every now and then, which is why the need for remote patient monitoring is increasing.

As per P&S Intelligence, this will be a key factor to take the digital health market from $101.4 billion in 2019 to $884.1 billion by 2030, at a high 21.8% CAGR between 2020 and 2030. This is because among many of its offerings, digital health includes connected devices, which are being used to monitor various aspects of people’s health and medical condition in their homes. By using the internet connection of patients’ homes, these devices automatically send the gathered data to the server of the doctor for analysis and action, thus offering the elderly immense convenience and comfort.

The level of mHealth usage can be gauged from a survey conducted by Google and Cornell University that revealed that of all the mobile apps downloaded in 2015, 44% were physical-activity-related apps, while 23% were specialized medical apps. Just like connected devices, these applications transmit the data via the internet to doctors, who then connect with patients remotely or send reminders about in-person visits. Such apps are becoming increasingly popular with the launch of advanced communication technologies such as 4G and 5G, which allow for fast data transfer.

Therefore, as governments invest in holistic care, the adoption of digital health solutions will boom in emerging and advanced economies. 

Read More

Huge Growth Expected in European Drug of Abuse Testing Market in Future

 For many people in Europe, especially emotionally disturbed teens, drugs are their best friends! But, as everyone knows, whether an addict or not, drugs are not good. Though they help people escape their troubles for a while, they lead to long-lasting ill-effects, such as risk of AIDS and hepatitis C. Due to the increasing concerns among relatives and friends about drug abuse by their loved ones, they are rapidly using methods to test the presence of such substances in the body of suspected users.  

Thus, with the rising prevalence of drug abuse in the continent, the European drug of abuse testing market is predicted to grow to $3.0 billion by 2023, from $1.7 billion revenue in 2017, at a 9.6% CAGR during 2018–2023. Such kits and products can be used to determine the presence of a number of toxicants in the body, including amphetamines, opiates, alcohol, cannabis, cocaine, and ecstasy, commonly known as MDMA, which is short for its chemical formula 3,4-methylenedioxymethamphetamine. 

The largest DOA testing market in Europe has been the U.K., and the situation will be the same in the coming years, owing to the growing problem of drug abuse in the kingdom. According to the National Health Service (NHS), in 2018–19, 7,376 people were admitted to the hospital with drug-induced mental and behavioral disorders, which was a 30% increase from the 5,668 admissions reported in 2008–09. Moreover, rising by 16% from 2012–13, the number of hospital admissions due to drug poisoning in the kingdom stood at 18,053 in 2018–19. 

Therefore, with the growing issue of DOA usage in Europe, the volume of tests is swiftly rising.

Read More

Rising Cases of Food-Borne Zoonotic Diseases in U.S. Driving Focus on Animal Healthcare

The surging prevalence of foodborne zoonotic diseases in the U.S. is creating a huge requirement for animal healthcare products. Such diseases are caused by the intake of water or food contaminated by pathogenic microorganisms, such as viruses, parasites, and bacteria. These disease-causing microorganisms enter the animal body through the gastrointestinal tract, where the initial symptoms are observed. Most common foodborne zoonotic diseases are caused by listeria, salmonella, E. coli, campylobacter, yersinia, trichinella, cryptosporidium, toxoplasma, giardia, and toxins of Clostridium perfringens, Bacillus cereus, Staphylococcus aureus, and Clostridium botulinum, which can be eliminated by certain animal healthcare products.  

U.S. Animal Healthcare Market Outlook

Additionally, the increasing domestic consumption and export of meat and milk will support the U.S. animal healthcare market growth in the coming years. For instance, according to the U.S. Meat Export Federation (USMEF), between January 2021 and May 2021, the country exported 408,896 metric tons (mt), 325,747 mt, 174,280 mt, 92,437 mt, 81,203 mt, 57,723 mt, 59,604 mt, and 56,290 mt pork to China/Hong Kong, Mexico, Japan, Canada, South Korea, Central America, South America, and the Association of Southeast Asian Nation (ASEAN) members, respectively. 

In recent years, companies operating in the U.S. animal healthcare market have been focusing on mergers and acquisitions and partnerships to capture a vast customer base. For example, in May 2018, Zoetis Inc. acquired Abaxis Inc., a veterinary point-of-care diagnostic instruments provider. Some of the other companies opting for such measures are Elanco Animal Health, C.H. Boehringer Sohn AG & Co. KG, Vetoquinol S.A, Bayer AG, HIPRA, Virbac Group, Huvepharma, Ceva Santé Animale, and Dechra Pharmaceuticals plc.

Thus, the rising prevalence of foodborne zoonotic diseases, surging domestic consumption and exports of milk and meat, and increasing adoption of companion animals will accelerate the consumption of animal healthcare products in the U.S. in the foreseeable future.  

Explore Full Report Description At: https://www.psmarketresearch.com/market-analysis/us-animal-healthcare-market

Read More